About 42,338 results

ALLMedicine™ Osteoporosis Center

Research & Reviews  13,973 results

Quality of Life in Women over 65 Years of Age Diagnosed with Osteoporosis.
International Journal of Environmental Research and Publi... Pastor-Robles MB, Mayo-Íscar A et. al.

May 15th, 2022 - (1) Background: Today's society is moving towards active aging, underlining the importance of understanding and improving quality of life (QoL). This QoL in women over the age of 65 years diagnosed with osteoporosis was compared with the QoL of th...

Coping Strategies Preferred by Patients Treated for Osteoporosis and Analysis of the Di...
International Journal of Environmental Research and Publi... Barańska A, Religioni U et. al.

May 15th, 2022 - Osteoporosis has been recognized as a civilization disease. This chronic condition needs a long-term management plan with a holistic approach to patients. The specificity of the patient's response to the disease and coping strategies are very impo...

Intravenous neridronate is effective in regional migratory osteoporosis.
Rheumatology (Oxford, England); D'Alessandro R, Falsetti P et. al.

May 15th, 2022 - Intravenous neridronate is effective in regional migratory osteoporosis.|2022|D'Alessandro R,Falsetti P,Bardelli M,Gentileschi S,Baldi C,|

Sclerostin is a promising therapeutic target for oral inflammation and regenerative den...
https://doi.org/10.1186/s12967-022-03417-4 10.1086/301721 10.1086/302416 10.1359/jbmr.080216 10.1016/j.bone.2004.05.023 10.3390/ijms21093199 10.3389/fimmu.2021.602330 10.1007/s40265-019-01072-6 10.1086/318811 10.1093/hmg/10.5.537 10.1089/gte.2008.0036 10.1002/humu.21274 10.1136/jmg.39.2.91 10.1002/ajmg.10401 10.1359/jbmr.090411 10.1074/jbc.M705092200 10.1007/s10735-007-9096-3 10.1093/emboj/cdg599 10.1359/jbmr.061002 10.1084/jem.20031454 10.1002/jbmr.304 10.1074/jbc.M301716200 10.1074/jbc.M504308200 10.1016/j.bone.2020.115708 10.1371/journal.pone.0025900 10.1210/jc.2017-02163 10.1002/jbmr.3452 10.1177/1060028020952764 10.3389/fimmu.2018.02467 10.1002/j.1875-595X.2001.tb00840.x 10.1016/j.bone.2005.02.019 10.1902/jop.2015.150270 10.3390/medicina57080788 10.1016/j.cyto.2018.10.021 10.1007/s10266-020-00520-0 10.1002/JPER.21-0494 10.1111/jcpe.12245 10.1111/jicd.12369 10.1111/j.1600-0765.2009.01227.x 10.1177/0022034515581372 10.1016/j.archoralbio.2015.11.010 10.1016/j.archoralbio.2014.08.013 10.1186/s12967-018-1438-2 10.1016/j.devcel.2020.06.006 10.1016/j.joen.2010.11.025 10.1177/0022034518771331 10.1093/ejo/cjv006 10.1371/journal.pone.0167312 10.1177/0022034518766874 10.1902/jop.2015.150083 10.1902/jop.2014.140230 10.1002/jcp.28684 10.7717/peerj.5808 10.1016/j.ajpath.2016.06.013 10.1016/j.biocel.2019.105628 10.1177/0022034517698104 10.3389/fbioe.2019.00430 10.1590/1807-3107bor-2019.vol33.0058 10.1016/j.aanat.2012.02.014 10.1002/jbmr.2690 10.3389/fcell.2021.778015 10.1016/j.bone.2012.10.013 10.1210/jc.2010-0067 10.1038/ijos.2014.12 10.1038/s41598-020-73026-y 10.1002/jbmr.5650081307 10.1111/j.1600-0501.2011.02375.x 10.1155/2014/617032 10.1016/S0140-6736(04)16627-0 10.1016/j.gene.2011.09.031 10.1002/jcp.24972 10.5114/aoms.2012.28810 10.1111/j.1600-0722.2008.00533.x 10.1016/j.ajodo.2020.08.006 10.1007/s002239900189 10.1369/0022155420960403 10.1177/08959374010150011201 10.1177/154405910408301202 10.1016/j.dental.2009.04.006 10.1177/154405910608500405 10.1046/j.1365-2842.2003.00959.x 10.1177/0022034509338340 10.1177/0022034516677539 10.3390/ijms141021140 10.4049/jimmunol.176.5.2880 10.1016/j.imbio.2010.08.006 10.1016/j.jdent.2017.05.001 10.1016/j.archoralbio.2004.11.009 10.1111/j.1601-0825.2006.01346.x 10.1136/annrheumdis-2013-203345 10.1359/jbmr.090403 10.1186/ar4305 10.1007/s00441-014-1799-7 10.1016/j.semnephrol.2009.07.002 10.22203/eCM.v037a11 10.3389/fcell.2020.605996 10.1002/jbmr.217 10.1016/j.bone.2013.10.019 10.1126/scitranslmed.aac4351 10.1186/s12967-020-02664-7 10.1002/JPER.16-0435 10.1002/jbmr.1984 10.1111/jre.12254 10.1902/jop.2008.070624 10.1096/fj.14-265496 10.2106/JBJS.K.00344 10.1002/art.37697 10.1089/ten.tea.2018.0013 10.1016/j.actbio.2021.11.046 10.1016/j.actbio.2018.06.017 10.1016/j.archoralbio.2016.11.012 10.22203/eCM.v037a20 10.1016/j.jmbbm.2021.104771 10.1007/s11914-020-00652-w 10.1007/s00198-021-06095-y 10.1210/clinem/dgab623 10.1093/ndt/gfy129
Journal of Translational Medicine; Liao C, Liang S et. al.

May 14th, 2022 - Sclerostin is the protein product of the SOST gene and is known for its inhibitory effects on bone formation. The monoclonal antibody against sclerostin has been approved as a novel treatment method for osteoporosis. Oral health is one of the esse...

Screening for osteoporosis using L1 vertebral density on abdominal CT in an Australian ...
Clinical Radiology; Abbouchie H, Raju N et. al.

May 14th, 2022 - To assess the utility of osteoporosis screening using abdominal computed tomography (CT) versus dual-energy X-ray absorptiometry (DXA) T-scores as the reference. Patients ≥30 years undergoing abdominal CT and DXA within 12 months were assessed ret...

see more →

Guidelines  64 results

Management guideline for Werner syndrome 2020. 4. Osteoporosis associated with Werner s...
Geriatrics & Gerontology International; Mori S, Takemoto M et. al.

Nov 7th, 2020 - Management guideline for Werner syndrome 2020. 4. Osteoporosis associated with Werner syndrome.|2020|Mori S,Takemoto M,Kubota Y,Taniguchi T,Motegi SI,|methods,therapeutic use,diagnosis,etiology,prevention & control,complications,diagnosis,drug the...

Ankle fractures in the elderly: Current concepts.
Injury Pearce O, Al-Hourani K et. al.

Nov 7th, 2020 - Ankle fractures remain the third most common musculoskeletal injury in the elderly population. The presence of osteoporosis, significant multiple comorbidities and limited functional independence makes treatment of such injuries challenging. Early...

Medical Care of Adults With Down Syndrome: A Clinical Guideline.
JAMA Tsou AY, Bulova P et. al.

Oct 21st, 2020 - Down syndrome is the most common chromosomal condition, and average life expectancy has increased substantially, from 25 years in 1983 to 60 years in 2020. Despite the unique clinical comorbidities among adults with Down syndrome, there are no cli...

Core principles for fracture prevention: North American Consensus from the National Ost...
Osteoporosis International : a Journal Established as Res... Lewiecki EM, Binkley N et. al.

Jul 18th, 2020 - Core principles for fracture prevention address fundamental concepts for the evaluation and management of patients at risk for fracture. These are intended to form the foundation of clinical practice guidelines and represent a first step toward gu...

Endocrine Practice : Official Journal of the American Col... Camacho PM, Petak SM et. al.

May 20th, 2020 - Objective: The development of these guidelines is sponsored by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols ...

see more →

Drugs  261 results see all →

Clinicaltrials.gov  588 results

Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia

May 13th, 2022 - Propionic acidemia (PA) is one of the most common inborn errors of organic acid metabolism. Although this disorder is now routinely detected in the immediate neonatal period on the US newborn screen, clinical outcomes are poor despite timely and a...

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis

May 13th, 2022 - Systemic mastocytosis is a disorder caused by clonal mast cell proliferation and release of mast cell mediators including tryptase. As a result, mast cell numbers may increase and affect target organs including the dermis (maculopapular cutaneous ...

Involvement of Skeletal Muscle Fibrocytes in sarcOpenia in Patients With Chronic ObstRuctive bronchopneumopaThia

May 13th, 2022 - Chronic obstructive pulmonary disease (COPD) is a common and potentially serious chronic inflammatory respiratory disease. It has an estimated prevalence of 12% in Europe, making it a major public health issue. It is currently the third leading ca...

Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries

May 13th, 2022 - Major orthopedic procedures, including total joint replacement and spine surgeries, are among the most common procedures in the population. Learning about how often these surgeries are performed can give indications of whether the treatment of art...

Clinical and Laboratory Study of Methylmalonic Acidemia

May 13th, 2022 - Methylmalonic acidemia (MMA), one of the most common inborn errors of organic acid metabolism, is heterogeneous in etiology and clinical manifestations. Affected patients with cblA, cblB and mut classes of MMA are medically fragile and can suffer ...

see more →

News  1,986 results

Breast Cancer Test Recommended for Extended Endocrine Therapy

May 10th, 2022 - In an updated clinical practice guideline, the American Society of Clinical Oncology has named the Breast Cancer Index (BCI) as the only genomic test that should be used to guide extended endocrine therapy decisions for women with early-stage, hor...

Using DEXA to Grade Hip OA Could Aid Diagnosis, Prognosis

Apr 29th, 2022 - Bone densitometry scans provide useful information that can be used to classify radiographic hip osteoarthritis more objectively than does currently used methods, UK researchers believe. Based on detecting osteophytes using high-resolution dual en...

Could NSAIDs Negate Bisphosphonate Benefits?

Apr 20th, 2022 - Nonsteroidal anti-inflammatory drugs (NSAIDs) seemed to neutralize the protective benefit of a certain bisphosphonate, according to a post-hoc analysis of a randomized controlled trial. Among over 5,200 community-dwelling women ages 75 and older, ...

Unraveling primary ovarian insufficiency
Mark P. Trolice, MD

Apr 15th, 2022 - In the presentation of secondary amenorrhea, pregnancy is the No. 1 differential diagnosis.

NICE Makes a U-turn on Romosozumab, Recommends it for Postmenopausal Osteoporosis

Apr 5th, 2022 - In draft guidance published last week, the National Institute for Health and Care Excellence (NICE) has recommended romosozumab for the treatment of osteoporosis in postmenopausal women. With this decision, more than 20,000 individuals in England ...

see more →

Patient Education  63 results see all →